BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · IEX Real-Time Price · USD
0.581
+0.005 (0.94%)
Apr 26, 2024, 12:21 PM EDT - Market open
BioLineRx Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for BioLineRx stock have an average target of 12.5, with a low estimate of 4.00 and a high estimate of 21. The average target predicts an increase of 2,052.57% from the current stock price of 0.58.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioLineRx stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +3,516.33% | Apr 17, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +3,516.33% | Mar 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +3,516.33% | Feb 29, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +3,516.33% | Nov 20, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $19 → $21 | Strong Buy | Maintains | $19 → $21 | +3,516.33% | Sep 15, 2023 |
Financial Forecast
Revenue This Year
n/a
from 4.80M
Revenue Next Year
n/a
EPS This Year
n/a
from -0.06
EPS Next Year
n/a
Revenue Forecast
Revenue |
---|
High |
Avg |
Low |
Revenue Growth
Revenue Growth |
---|
High |
Avg |
Low |
EPS Forecast
EPS |
---|
High |
Avg |
Low |
EPS Growth
EPS Growth |
---|
High |
Avg |
Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.